share_log

復星醫藥:海外監管公告 - 關於參與設立的投資基金完成私募投資基金備案的公告

FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Hong Kong Stock Exchange ·  Apr 22 05:41
Summary by Moomoo AI
上海復星醫藥(集團)股份有限公司(簡稱「復星醫藥」)宣布其控股子公司/企業上海復毓晟健企業管理合伙企業(有限合伙)及寧波復瀛投資有限公司與其他投資人共同出資設立的兩個平行基金——安吉復毓承祥創業投資合伙企業(有限合伙)及徐州復毓彭泰創業投資合伙企業(有限合伙),已於近日在中國證券投資基金業協會完成備案。這兩個基金將聘請復星醫藥控股子公司上海復健股權投資基金管理有限公司擔任基金管理人,並將在滿足各自決策機制約定的條件下共同實施對外投資。該消息於2024年4月22日由復星醫藥董事會公告。
上海復星醫藥(集團)股份有限公司(簡稱「復星醫藥」)宣布其控股子公司/企業上海復毓晟健企業管理合伙企業(有限合伙)及寧波復瀛投資有限公司與其他投資人共同出資設立的兩個平行基金——安吉復毓承祥創業投資合伙企業(有限合伙)及徐州復毓彭泰創業投資合伙企業(有限合伙),已於近日在中國證券投資基金業協會完成備案。這兩個基金將聘請復星醫藥控股子公司上海復健股權投資基金管理有限公司擔任基金管理人,並將在滿足各自決策機制約定的條件下共同實施對外投資。該消息於2024年4月22日由復星醫藥董事會公告。
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) ANNOUNCES TWO PARALLEL FUNDS JOINTLY ESTABLISHED BY ITS HOLDING SUBSIDIARY/ENTERPRISE SHANGHAI FUYU SHENGJIAN ENTERPRISE MANAGEMENT PARTNERSHIP (LIMITED PARTNERSHIP) AND NINGBO FUYING INVESTMENT CO., LTD. WITH OTHER INVESTORS — ANJI FUXING The Startup Investment Partnership (Limited Partnership) and Xuzhou Fuyu Pengtai Venture Investment Partnership (Limited Partnership) have recently completed their filing with the Securities Investment Fund Industry Association of China. The two funds will hire Shanghai Rehabilitation Equity Investment Fund Management Co., Ltd., a subsidiary of Resusstar Pharmaceutical Holdings, as fund managers and will jointly implement foreign investments under the conditions agreed in their respective decision-making mechanisms. The news was announced by the Board of Directors of Fustar Pharmaceuticals on April 22, 2024.
SHANGHAI FUSTAR PHARMACEUTICALS (GROUP) CO., LTD. (“FUSTAR PHARMACEUTICALS”) ANNOUNCES TWO PARALLEL FUNDS JOINTLY ESTABLISHED BY ITS HOLDING SUBSIDIARY/ENTERPRISE SHANGHAI FUYU SHENGJIAN ENTERPRISE MANAGEMENT PARTNERSHIP (LIMITED PARTNERSHIP) AND NINGBO FUYING INVESTMENT CO., LTD. WITH OTHER INVESTORS — ANJI FUXING The Startup Investment Partnership (Limited Partnership) and Xuzhou Fuyu Pengtai Venture Investment Partnership (Limited Partnership) have recently completed their filing with the Securities Investment Fund Industry Association of China. The two funds will hire Shanghai Rehabilitation Equity Investment Fund Management Co., Ltd., a subsidiary of Resusstar Pharmaceutical Holdings, as fund managers and will jointly implement foreign investments under the conditions agreed in their respective decision-making mechanisms. The news was announced by the Board of Directors of Fustar Pharmaceuticals on April 22, 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more